Increased Long-Term Cardiovascular Risk After Total Hip Arthroplasty
Authors:
- Max GordonMGMax Gordon
- Agata RysinskaARAgata Rysinska
- Anne GarlandAGAnne Garland
- Ola RolfsonOROla Rolfson
- Sara AspbergSASara Aspberg
- Thomas EislerTEThomas Eisler
- Göran GarellickGGGöran Garellick
- André StarkASAndré Stark
- Nils P. HailerNHNils P. Hailer
- Olof SköldenbergOSOlof Sköldenberg
Open Access
- 1 February 2016
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 95 (6) , e2662-7
Abstract
Total hip arthroplasty is a common and important treatment for osteoarthritis patients. Long-term cardiovascular effects elicited by osteoarthritis or the implant itself remain unknown. The purpose of the present study was to determine if there is an increased risk of late cardiovascular mortality and morbidity after total hip arthroplasty surgery. A nationwide matched cohort study with data on 91,527 osteoarthritis patients operated on, obtained from the Swedish Hip Arthroplasty Register. A control cohort (n = 270,688) from the general Swedish population was matched 1:3 to each case by sex, age, and residence. Mean follow-up time was 10 years (range, 7–21). The exposure was presence of a hip replacement for more than 5 years. The primary outcome was cardiovascular mortality after 5 years. Secondary outcomes were total mortality and re-admissions due to cardiovascular events. During the first 5 to 9 years, the arthroplasty cohort had a lower cardiovascular mortality risk compared with the control cohort. However, the risk in the arthroplasty cohort increased over time and was higher than in controls after 8.8 years (95% confidence interval [CI] 7.0–10.5). Between 9 and 13 years postoperatively, the hazard ratio was 1.11 (95% CI 1.05–1.17). Arthroplasty patients were also more frequently admitted to hospital for cardiovascular reasons compared with controls, with a rate ratio of 1.08 (95% CI 1.06–1.11). Patients with surgically treated osteoarthritis of the hip have an increased risk of cardiovascular morbidity and mortality many years after the operation when compared with controls.Keywords
This publication has 33 references indexed in Scilit:
- Atherosclerosis in rheumatoid arthritis: is it all about inflammation?Nature Reviews Rheumatology, 2015
- Periodontitis: from microbial immune subversion to systemic inflammationNature Reviews Immunology, 2014
- Relationship between circulating serum osteoprotegerin and total receptor activator of nuclear κ-B ligand levels, triglycerides, and coronary calcification in postmenopausal womenMenopause, 2014
- Cardiovascular events associated with the long-term use of NSAIDs: a review of randomized controlled trials and observational studiesExpert Opinion on Drug Safety, 2014
- Factors influencing health-related quality of life after total hip replacement - a comparison of data from the Swedish and Danish hip arthroplasty registersBMC Musculoskeletal Disorders, 2013
- Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)Osteoarthritis and Cartilage, 2013
- Hip arthroplastyThe Lancet, 2012
- Inflammation in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- RANKL Links Arterial Calcification With OsteolysisCirculation Research, 2009
- How prevalent are implant wear and osteolysis, and how has the scope of osteolysis changed since 2000?Journal of the American Academy of Orthopaedic Surgeons, 2008